2015;10:e0125192
Instead, they emphasize a physician-monitored protocol that uses GLP-1 peptides to help reset hunger cues, improve metabolic flexibility, and support behavioral changes that lead to real fat loss not just water or muscle depletion
Its gaining recognition for its effectiveness in promoting significant weight reduction when combined with a well-designed, supervised weight management plan
Substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders (heart attack, heart failure, ischemic stroke, and hemorrhagic stroke, pulmonary embolism, pulmonary hypertension, coagulopathy and clotting disorders) chronic kidney disease, COPD, pneumonia, liver failure, inflammatory bowel disease, liver cancer) all significantly declined
The cost for obesity drugs with list prices in the $1,000 to $1,350 range per month before insurance is a major roadblock for many patients who could benefit from significant weight loss and the reduced potential for related health issues
In the meantime, some patients on long half-life GLPs are already stretching injections to every 1014 days , especially during maintenance phases
